AGXArgan, Inc.
- Next report
- Dec 3
- Thursday, in 21 days · time not announced yet
- EPS expected
- $3.34
- quarter ending Oct 31, 2026
- Last result
- $3.24Beat
- vs $2.27 expected on Jun 3
- Stock move on it
- +3.96%
- two sessions around the report
- Price
- $315.10
- −2.14% today · $8.44B cap
Past and upcoming reports
2
| Dec 3, 2026 | Oct 31, 2026 | Time not announced yet | $3.34 | not yet | |
| Jun 3, 2026 | Apr 30, 2026 | Time not given | $2.27 | Beat$3.24 | +3.96%2d |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 3, 2026 report
Argan, Inc. Q1 EPS beats by 39%, shares rise modestly amid valuation concerns
Argan reported Q1 EPS of $3.24, beating estimates by 38.9%, with shares up 0.77% post-earnings. Despite strong EPS growth and solid fundamentals, valuation remains stretched with a forward P/E of 45.7, double the sector average. Investors await the next earnings call for updated guidance to assess sustainability of growth.
Reported against expected
BeatReported EPS of $3.24 beat the estimate of $2.33 by 38.9%.
Guidance
No explicit guidance update disclosed. growth outlook to be clarified at next earnings call.
How the stock reacted
Stock rose 0.77% on earnings day, reflecting modest positive sentiment despite valuation concerns.
What changed
Q1 EPS beat estimates by 38.9%, reported at $3.24 versus $2.33 consensus.
What the price now assumes
Modest 0.77% stock gain reflects cautious optimism amid stretched valuation multiples.
What it means for the business
Maintain a constructive bias. monitor next earnings call for growth guidance and margin trends.
The next one to three months, as we saw it then
Better case30%
Sustained strong EPS growth and margin expansion drive multiple re-rating and share appreciation.
Base case50%
EPS growth remains solid but valuation limits upside. stock trades sideways with moderate volatility.
Worse case20%
Growth slows sharply or guidance disappoints, triggering valuation multiple contraction and share price decline.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.